Stella Mental Health‘s recent Impact Report 2026 provides a data-filled snapshot of the company‘s results using its treatments on over 16,000 patients with posttraumatic stress, depression and other symptoms. The company, which uses stellate ganglion block (SGB) and other procedures to treat traumarelated symptoms, claims that the Body Results show the magnitude of the clinically significant improvements across Stella‘s entire patient group. As skepticism remains high over many new mental health offerings, the report provides results that speak for themselves rather than blatant marketing.
Stella Mental Health Impact Report 2026 The data indicates that, among the patient population included in the dataset, there is statistically significant relief of symptoms post treatment. The findings summarized in the Impact Report indicate reductions on measures that are relevant to PTSD, depression, and anxiety and, depending on the measure used, a significant proportion of patients moved from “clinical” to “subclinical” ranges. The key finding in the Impact Report is that, across most conditions, protocol, and measure, most of the patients’ distress falls into ranges indicative of better dayto-day functioning.
Stella‘s work is integrated with medical treatments such as SGB, assessment, and sometimes referral for further therapies. The Stella model is one piece of an overall model of traumainformed care. As the Impact Report 2026 notes, there were many who came to Stella with prior tried-and-true methods medication, talk therapy, or both already in place. For them, even partial relief can be life-changing.
Safety and patient experience are also discussed. Stella Mental Health emphasizes that low incidences of adverse events and high patient satisfaction scores show that their protocols are both tolerable and efficacious for most people. Longer term followups and independent research are seen as necessary to verify the long-term effects of treatment.
For patients and practitioners, the Stella Mental Health Impact Report 2026 is interesting but prompts the usual questions: who is a good candidate? How does this compare with current treatments? What about cost and access? While it doesn‘t help in all respects, it adds to a wealth of information on innovative treatments for traumarelated distress. As always, good clinical practice is to discuss these issues with your trusted clinician who will want to view them as just one more of many tools in your healing toolkit, rather than a panacea.
Source: Stella Mental Health Releases 2026 Impact Report Documenting Outcomes Across 16,176 Patients
Leave a Comment